Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0000947871-16-001312

Director bought 550,000 shares at $14.00 ($7,700,000)

  • Director acquired 1,177,995 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2016-06-27 Conversion : show line 1 in the form +11,111 12,193 I
2016-06-27 Conversion : show line 2 in the form +1,166,884 1,280,604 I
2016-06-27 Purchase : show line 3 in the form +5,189 $14.00 $72,646 17,382 I
2016-06-27 Purchase : show line 4 in the form +544,811 $14.00 $7,627,354 1,825,415 I
Open-market purchases · 550,000 sh · avg $14.00 · $7,700,000

Table II: Derivative

6 lines
Date Transaction Shares Underlying Owned after D/I
2016-06-27 Conversion : show line 5 in the form Series C Convertible Preferred Stock −3,628 3,628 0 I
2016-06-27 Conversion : show line 6 in the form Series C Convertible Preferred Stock −380,986 380,986 0 I
2016-06-27 Conversion : show line 7 in the form Series D Convertible Preferred Stock −739 739 0 I
2016-06-27 Conversion : show line 8 in the form Series D Convertible Preferred Stock −77,697 77,697 0 I
2016-06-27 Conversion : show line 9 in the form Series E Convertible Preferred Stock −4,351 6,744 0 I
2016-06-27 Conversion : show line 10 in the form Series E Convertible Preferred Stock −456,870 708,201 0 I
Loading xslF345X03/ss732_4.xml…